Stock

Insider Activity Roundup: Wednesday’s Top Buys and Sells Revealed

This article summarizes the most significant insider buying and selling activities reported for Wednesday, November 27, 2024.

Top Insider Buys:

AN2 Therapeutics, Inc. (NASDAQ:ANTX) saw substantial insider buying as director Robin Shane Readnour acquired 75,000 shares on November 26 and 27. The purchases were made at prices ranging from $1.3934 to $1.4169 per share, totaling approximately $105,685. These transactions were executed through MGC Venture Partners 2018 LP and MGC Venture Partners QP 2018 LP, entities over which Readnour has shared voting and dispositive power. Following these acquisitions, Readnour’s indirect ownership in the pharmaceutical company increased to 622,573 shares.

Passage BIO, Inc. (NASDAQ:PASG) experienced significant insider buying from Lynx1 Capital Management LP. The firm acquired 456,353 shares over three consecutive days, from November 25 to November 27, at prices ranging from $0.5641 to $0.7075 per share. The total value of these transactions amounted to $284,519. The purchases were made directly by Lynx1 Master Fund LP, with Lynx1 Capital Management LP acting as the investment manager. Following these acquisitions, Lynx1 Capital now holds a total of 8,883,308 shares in Passage BIO.

HomeStreet, Inc. (NASDAQ:HMST) director Joanne R. Harrell made notable purchases, acquiring a total of 3,964.206 shares on November 26 and 27. The transactions were executed at prices ranging from $11.52 to $11.6499 per share, with a total value of approximately $46,000. These acquisitions increased Harrell’s direct ownership to 18,870.842 shares in the Seattle-based state commercial bank.

Myers Industries Inc . (NYSE:NYSE:MYE) director Frederic Jack Liebau Jr. purchased 7,000 shares at a weighted average price of $11.68 per share on November 27. The total transaction value amounted to $81,760, increasing Liebau’s direct ownership to 56,993 shares. This acquisition demonstrates continued confidence in the Akron, Ohio-based company known for its diverse range of plastic products and services.

PBF Energy Inc. (NYSE:NYSE:PBF) saw significant insider buying from Control Empresarial de Capitales S.A. de C.V., a major shareholder. The entity acquired 277,000 shares on November 25 and 26, at prices ranging from $31.4499 to $31.6953 per share. The total transaction value was approximately $8.7 million. Following these purchases, Control Empresarial now holds 26,959,498 shares, representing about 23.4% of PBF Energy’s outstanding Class A Common Shares.

Top Insider Sells:

Hilton Grand Vacations Inc . (NYSE:NYSE:HGV) experienced a substantial insider sale as Apollo Principal Holdings A GP Ltd sold 4 million shares on November 25. The transaction was executed at $42.10 per share, totaling $168.4 million. Following this sale, Apollo retains ownership of 26,295,825 shares in the company.

Cloudflare, Inc. (NYSE:NYSE:NET) President and COO Michelle Zatlyn sold shares totaling approximately $8.95 million on November 25, 26, and 27. The transactions involved multiple sales of Class A Common Stock at prices ranging from $100.35 to $106.30 per share. These sales were part of a predetermined trading plan adopted under Rule 10b5-1.

Vertiv Holdings Co (NYSE:NYSE:VRT) Chief Technology Officer and Executive Vice President Stephen Liang sold 86,619 shares on November 26, with prices ranging from $130.79 to $131.46 per share. The total value of these sales amounted to approximately $11.35 million. Liang also exercised options to acquire 69,862 shares at prices ranging from $11.50 to $15.84.

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Chief Development Officer Suneel Gupta sold shares totaling approximately $5.6 million over two days, with prices ranging from $45.50 to $46.04 per share. Gupta also exercised stock options, acquiring shares at prices ranging from $7.38 to $12.17, totaling approximately $1.7 million.

Dolby Laboratories , Inc. (NYSE:NYSE:DLB) President and CEO Kevin Yeaman sold shares totaling approximately $4.66 million on November 25 and 26. The sales occurred at prices ranging from $80.19 to $81.1764 per share. Yeaman also exercised stock options, acquiring 57,888 shares at $62.32 per share, which were then sold.

Investors should stay informed about insider buying and selling activities as they can provide valuable insights into a company’s internal perspective. While insider transactions alone should not be the sole basis for investment decisions, they can be an important factor to consider alongside other financial and market data when evaluating potential investment opportunities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You May Also Like

Editor's Pick

Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

Economy

LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

Editor's Pick

Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

Latest News

Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 beneficialinvestmentnow.com

Exit mobile version